NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) wishes to call attention to its scheduled AGM, to which all CHV shareholders and debenture holders are invited.
Date & Time: Thursday 11 January 2018 at 10:00 AM
Venue: Canada House Headquarters
1773 Bayly Street
Pickering, ON L1W 2Y7
Agenda:
Formal AGM
- Welcome and call meeting to order
- Quorum determination
- Presentation of financial statements.
- Election of directors
- Appointment of auditors
- Termination of formal business
Informal Presentations
- Presentations by
- Riley McGee, President, Abba Medix Inc
- Mike Southwell, President, Marijuana for Trauma
- Paul Methot, President, Knalysis Technologies
- Visit and walk-through Abba Medix grow facility
- Lunch & open discussions
The Company encourages all CHV shareholders and debenture holders to join us at our AGM Thursday morning this week!
Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca. or www.sedar.com
Cautionary Statement Regarding Forward‐Looking Information. Certain statements within this news release pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the financing, regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Company’s public disclosure record. The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.